Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112979701A details a novel nickel-catalyzed resolution for L-glufosinate-ammonium. Achieve >95% yield and ee value with significant cost reduction in agrochemical manufacturing.
Patent CN107586796A reveals enzymatic synthesis for high-purity chiral amines. Offers scalable cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102978251A reveals a low-cost enzymatic route for L-tert-leucine. Achieve >99% optical purity and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104926813A enables high-yield asymmetric catalysis. Delivers supply chain stability and cost advantages for pharmaceutical intermediates manufacturing globally.
Novel AlCl3-catalyzed cyclization route for fungicide intermediates. Offers simplified purification and scalable production for agricultural chemical manufacturers.
Patent CN100509748C reveals efficient purification for pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with advanced inorganic base catalysis.
Patent CN104561136B enables high-yield chemo-enzymatic synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Novel L-threonine aldolase enables green synthesis of antibiotic intermediates with high stereoselectivity and reduced environmental impact.
Patent CN111018928A reveals a novel 2-step synthesis for high-purity gastrodin hemihydrate, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN113816925A reveals a high-yield Trifarotene synthesis route. Eliminating n-butyllithium enhances safety and reduces manufacturing costs for global supply chains.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.
Patent CN109749968B reveals a novel Bacillus velezensis strain for synthesizing chiral intermediates. This breakthrough offers significant cost reduction in API manufacturing and superior supply chain reliability.
Novel electrophilic substitution route for 3-hydroxymethyl-4-hydroxymandelic acid. Reduces steps, lowers cost, ensures high purity for asthma medication supply chains.
Patent CN115850076B reveals metal-free photoredox method for difluoromethylene introduction, offering cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN115073351A reveals a green, water-based method for 3,3'-bisindolylmethanes using ion-pair catalysis, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN111229311B reveals a green synthesis method for 2-amino-3-cyano-4H-pyran compounds using KIT-6 supported ionic liquids, offering high yields and recyclability for pharmaceutical supply chains.
Patent CN121495896A reveals enhanced enzyme catalysis for chiral amine synthesis offering significant cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN101824438B details microbial synthesis of high-purity (S)-EHB using yeast. Offers cost-effective, scalable pharmaceutical intermediate solutions.
Patent CN110862324A discloses a novel iridium-catalyzed asymmetric reductive amination method achieving up to 95% ee for key pharmaceutical intermediates like Cinacalcet.
Novel oxidation method for Tenofovir intermediate ensures high purity and yield. Offers significant cost reduction and supply chain reliability for API manufacturing partners globally.